ZNF148-RPRD2 Fusion FISH Probe
The ZNF148-RPRD2 Fusion FISH Probe is used to confirm a fusion of the ZNF148 and RPRD2 genes. The fusion of the ZNF148 and RPRD2 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ZNF148-RPRD2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ZNF148-RPRD2-20-AQAQ | 20 (40 μL) | 200 μL |
|
ZNF148 Gene Summary
The protein encoded by this gene is a member of the Kruppel family of zinc finger DNA binding proteins. The encoded protein activates transcription of the T-cell receptor and intestinal alkaline phosphatase genes but represses transcription of the ornithine decarboxylase, vimentin, gastrin, stomelysin, and enolase genes. Increased expression of this gene results in decreased patient survival rates from colorectal cancer, while mutations in this gene have been associated with global developmental delay, hypoplastic corpus callosum, and dysmorphic facies. [provided by RefSeq, Feb 2017]
Gene Name: Zinc Finger Protein 148
Chromosome: CHR3: 124944512 -125094198
Locus: 3q21.2
RPRD2 Gene Summary
The Regulation Of Nuclear Pre-mRNA Domain Containing 2 (RPRD2) gene is located on chr1 :150336989-150449041 at 1q21.2.
Gene Name: Regulation Of Nuclear Pre-mRNA Domain Containing 2
Chromosome: CHR1: 150336989 -150449041
Locus: 1q21.2
Gene Diseases
The ZNF148 RPRD2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|